Work

PLN-74809 Shows Favorable Safety and Tolerability and Indicates Antifibrotic Activity in a Phase 2a Study for the Treatment of Idiopathic Pulmonary Fibrosis

Year: 2023

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2777

Authors: L.H. Lancaster, V. Cottin, M. Ramaswamy, J.G. Goldin, G.H.J. Kim, J. Bellini, M. Jurek, M. Decaris, G.P. Cosgrove, E. Lefebvre, K.R. Flaherty

Institutions: Vanderbilt University, Vanderbilt University Medical Center, Hôpital Louis Pradel, Cone Health, University of California, Los Angeles, Pliant (United States), University of Michigan

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367606871

Cites:

Cited by: 4

Related to: 10